Abstract:Antibiotic selection for the maintenance of expression plasmids is discouraged in the production of recombinant proteins for pharmaceutical or other human uses due to the risks of antibiotic residue contamination of the final products and the release of DNA encoding antibiotic resistance into the environment. We describe the construction of expression plasmids that are instead maintained by complementation of the lgt gene encoding a (pro)lipoprotein glyceryl transferase essential for the biosynthesis of bacterial lipoprotein. Mutations in lgt are lethal in Escherichia coli and other Gram-negative organisms. The lgt gene was deleted from E. coli and complemented by the Vibrio cholerae-derived gene provided in trans on a temperature-sensitive plasmid, allowing cells to grow at 30°C but not at 37°C. A temperature-insensitive expression vector carrying the V. cholerae-derived lgt gene was constructed, whereby transformants were selected by growth at 39°C. The vector was successfully used to express two recombinant proteins, one soluble and one forming insoluble inclusion bodies. Reciprocal construction was done by deleting the lgt gene from V. cholerae and complementing the lesion with the corresponding gene from E. coli The resulting strain was used to produce the secreted recombinant cholera toxin B subunit (CTB) protein, a component of licensed as well as newly developed oral cholera vaccines. Overall, the lgt system described here confers extreme stability on expression plasmids, and this strategy can be easily transferred to other Gram-negative species using the E. coli-derived lgt gene for complementation.IMPORTANCE Many recombinant proteins are produced in bacteria from genes carried on autonomously replicating DNA elements called plasmids. These plasmids are usually inherently unstable and rapidly lost. This can be prevented by using genes encoding antibiotic resistance. Plasmids are thus maintained by allowing only plasmid-containing cells to survive when the bacteria are grown in medium supplemented with antibiotics. In the described antibiotic-free system for the production of recombinant proteins, an essential gene is deleted from the bacterial chromosome and instead provided on a plasmid. The loss of the plasmid becomes lethal for the bacteria. Such plasmids can be used for the expression of recombinant proteins. This broadly applicable system removes the need for antibiotics in recombinant protein production, thereby contributing to reducing the spread of genes encoding antibiotic resistance, reducing the release of antibiotics into the environment, and freeing the final products (often used in pharmaceuticals) from contamination with potentially harmful antibiotic residues.

A new method for protein coexpression in Escherichia coli using two incompatible plasmids.

Coexpression of DNA Fragmentation Factor Subunits in E.coli by Two Incompatible Plasmids.

Improving aquaporin Z expression in Escherichia coli by fusion partners and subsequent condition optimization

Expression of Human Interferon Α-2B and Escherichia Coli Methionine Aminopeptidase Genes in a Single Host Using Two Incompatible Plasmids.

Construction and Application of the Vectors to Identify Genes Encoding Exported Proteins of Escherichia Coli.

Construction of the eukaryotic expression plasmid compatible with the detection system of shuttle plasmid pZ189

Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia Coli Vectors.

Functional Analysis of E. Coli Class II Release Factor RF3 Mutants

Expression of human β-defensin-2 with multiple joined genes in Escherichia coli

Conjugational Delivery of Chromosomal Integrative Constructs for Gene Expression in the Carbendazim-Degrading Rhodococcus Erythropolis D-1

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

Expression of human beta-defensin-2 with multiple joined genes in Escherichia coli.

EcoExpress-Highly Efficient Construction and Expression of Multicomponent Protein Complexes in Escherichia Coli.

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae

Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide

Biased Expression, under the Control of Single Promoter, of Human Interferon Α-2B and Escherichia Coli Methionine Amino Peptidase Genes in E. Coli, Irrespective of Their Distance from the Promoter.

Multilevel Systematic Optimization To Achieve Efficient Integrated Expression of Escherichia coli

Three Novel Escherichia Coli Vectors for Convenient and Efficient Molecular Biological Manipulations

Bicistronic expression plasmid for the rapid production of recombinant fused proteins in Escherichia coli

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Simple and Efficient Method for Heterologous Expression of Clostridial Proteins